Perrigo Company plc Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities
Perrigo Company plc (PRGO) reported Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities of $19.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities · last filed 2026-02-26
- Perrigo Company plc unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2025 was $19.60M, a 1681.82% increase from fiscal 2024.
- Perrigo Company plc unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2024 was $1.10M, a 97.82% decline from fiscal 2023.
- Perrigo Company plc unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2023 was $50.40M, a 149.50% increase from fiscal 2022.
- Perrigo Company plc unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2022 was $20.20M, a 94.13% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 6 month | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 12 month |
|---|---|---|
| 2025-12-31 | $19.60M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $1.10M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $50.40M 10-K · filed 2025-02-28 | |
| 2022-12-31 | $20.20M 10-K · filed 2024-02-27 | |
| 2021-12-31 | $344.10M 10-K · filed 2023-02-28 | |
| 2019-12-31 | $3.00M 10-K · filed 2021-03-01 | |
| 2018-12-31 | $6.50M 10-K · filed 2020-02-27 | |
| 2017-12-31 | $11.10M 10-K · filed 2019-02-27 | |
| 2016-12-31 | $2.40M 10-K · filed 2018-03-01 | |
| 2015-12-31 | $15.30M 10-K · filed 2018-03-01 | |
| 2015-06-27 | $1.40M 10-K · filed 2017-05-22 | |
| 2014-06-28 | $0.00 10-K · filed 2015-08-13 | |
| 2013-06-29 | $7.50M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |